Companies: 10,795·Total market cap: $144.5T
Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc.

LIPOOTCHealthcare● Active
$0.10
$-0.01(-4.76%)
Market Cap$462084
P/E Ratio
52W High$3.17
52W Low$0.02
Overview

Lipella Pharmaceuticals Inc. (LIPO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LIPO · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-2.60lipo eps ttm · lipo earnings per shareEarnings history
PE Ratio (TTM)lipo pe ratio ttm · lipo price to earningsPE Ratio deep dive
Revenue (TTM)173666.00lipo revenue ttm · lipo annual revenueFull revenue history
Dividend YieldNo Dividenddoes lipo pay dividends · lipo dividend yieldDividend history
Shares Outstanding1.0Mlipo shares outstanding · lipo floatShares outstanding history
Next EarningsSep 2, 2026Est.lipo earnings date · lipo next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$536357.00▲ +19.29% YoY
202220232024
lipella pharmaceuticals inc. revenue · lipo revenue 2024
FY 2024Net Income-$5.0M▼ 8.60% YoY
202220232024
lipella pharmaceuticals inc. net income · lipo profit 2024
FY 2024EPS$-4.79▲ +22.24% YoY
202220232024
lipo eps · lipella pharmaceuticals inc. earnings per share 2024
TTM:Revenue: $173666.00Net Income: -$5.3MEPS: $-2.60View income statement →

Stock Performance

Full History
1D-4.76%
1W+8.70%
1M+233.33%
3M-35.53%
YTD-44.44%
1Y-96.56%
5Y-98.26%

About Lipella Pharmaceuticals Inc.

CEOJonathan Kaufman
IPO DateDec 19, 2022
Employees5
CountryUS

Lipella Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm specializing in the creation of novel therapies. The company achieves this by repurposing and optimizing the active ingredients …

what is lipella pharmaceuticals inc. · lipo stock overview · lipella pharmaceuticals inc. company profile · who is lipella pharmaceuticals inc. ceo · lipo OTC · lipella pharmaceuticals inc. headquarters · lipella pharmaceuticals inc. business segments

About Stock Overview & Key Data

Lipella Pharmaceuticals Inc. (LIPO) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 19, 2022. As of the latest trading session, LIPO stock price is $0.10, with a market capitalization of $462,084. The stock has returned -96.56% over the past 12 months and -44.44% year-to-date.

In fiscal year 2024, Lipella Pharmaceuticals Inc. reported revenue of $536357.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Lipella Pharmaceuticals Inc. (LIPO) stock price is $0.10. The stock is traded on OTC under the ticker symbol LIPO. The 52-week range is $0.02 – $3.17.

LIPO stock priceLIPO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice